News from neuclone A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 17, 2018, 08:30 ET NeuClone Announces its Sixth Biosimilar Candidate Perjeta(R) (Pertuzumab) for use in Combination Therapy with Herceptin(R) (Trastuzumab)

NeuClone Pharmaceuticals Ltd. (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar...


Oct 23, 2018, 09:00 ET NeuClone Announces First Human Dose of Herceptin® (trastuzumab) Biosimilar Candidate in Phase I Clinical Trial

NeuClone Ltd, a biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced it has commenced...


May 10, 2018, 12:46 ET NeuClone gibt präklinische Ergebnisse von Biosimilar-Kandidaten für Stelara® (Ustekinumab) bekannt

Das biopharmazeutische Unternehmen NeuClone hat positive präklinische Ergebnisse des Biosimilars Stelara® von Johnson & Johnson bekannt gegeben –...


May 10, 2018, 08:00 ET NeuClone Announces Preclinical Results for Stelara® (ustekinumab) Biosimilar Candidate

Biopharmaceutical company NeuClone has announced positive preclinical results of its biosimilar to Johnson & Johnson's Stelara®, including...


May 10, 2018, 03:41 ET NeuClone communique les résultats précliniques du candidat biosimilaire du Stelara® (ustekinumab)

La société biopharmaceutique NeuClone a fait part de résultats précliniques positifs de son biosimilaire du Stelara® de Johnson & Johnson, comprenant ...